Atrial Fibrillation Perspective

• Feb 5 2021 This Week in Cardiology   Carotid screening, AF and alcohol, subcutaneous ICD, and medical education are the topics discussed by John Mandrola, MD, in this week’s podcast.
  theheart.org on Medscape, February 05, 2021
• Jan 29 2021 This Week in Cardiology   AF and COVID-19, microthrombi in COVID-19 autopsies, vericiguat, and POTS are the topics covered by John Mandrola, MD, in this week’s podcast.
  theheart.org on Medscape, January 29, 2021
• Antiplatelet Therapy: Where Do We Stand Now?   Can duration of DAPT be shortened? Is single antiplatelet therapy an option? Drs Bangalore and Baber discuss these topics in antiplatelet therapy and more.
  American College of Cardiology & Medscape , January 27, 2021
• ECG Challenge: Did COPD Cause This Man's Irregular Heart Rate? A middle-aged COPD patient is intubated after experiencing respiratory distress and is found to have an irregular heartbeat. What does his ECG show?
  Medscape Cardiology, January 25, 2021
• Jan 15 2021 This Week in Cardiology   COVID, ACE/ARBs, left atrial appendage closure, SGLT2 inhibitors, and a clue in AF mechanisms are the topics discussed by John Mandrola, MD, in this week’s podcast.
  theheart.org on Medscape, January 15, 2021
• Highlights in Mantle Cell Lymphoma From ASH 2020   Dr Amanda Cashen from Washington University reviews key studies on mantle cell lymphoma from ASH 2020, including new data on chemotherapy-free frontline options and CAR T-cell therapy.
  Medscape, December 29, 2020
• Mandrola's Top 10 in Cardiology for 2020 While the pandemic dominated the medical news, there were both exciting and concerning developments in the world of cardiology.
  theheart.org on Medscape, December 15, 2020
• Dec 11 2020 This Week in Cardiology   COVID, the clogged pipe frame of CAD, paclitaxel, and AF performance measures and Goodhart’s law are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, December 11, 2020
• Fish Oils and CV Prevention -- Now What?   Drs Tracy Wang and Renate Schnabel discuss new data on omega-3 fatty acids from the REDUCE-IT trial of icosapent ethyl. Do the STRENGTH, OMEMI, and VITAL Rhythm trials from the AHA meeting raise concerns?
  theheart.org on Medscape, November 25, 2020
• Nov 20 2020 This Week in Cardiology   COVID-19 vaccines and virtual AHA presentations on statins and the nocebo effect, high dose omega-3s, and AF ablation are the topics John Mandrola, MD, discusses on this week’s podcast.
  theheart.org on Medscape, November 20, 2020
• AHA 2020 EARLY-AF and STOP AF Put Electrophysiology at a Crossroads Seemingly positive data on earlier use of catheter ablation in patients with atrial fibrillation concerns some electrophysiologists.
  theheart.org on Medscape, November 17, 2020
• Nov 13 2020 This Week in Cardiology   COVID19 vaccines, thrombolysis in stroke, industry payments to doctors, and the upcoming AHA are topics covered by John Mandrola, MD, in this week’s podcast.
  theheart.org on Medscape, November 13, 2020
• AHA 2020 Read clinically focused news coverage of key developments from AHA 2020
  theheart.org on Medscape, November 10, 2020
• Mandrola Previews AHA 2020 A trial that aims to answer whether statin myalgia is drug related tops the picks. Studies on CT angiography, AF monitoring, fish oils, and a novel MRA will also feature at the 2020 American Heart Association meeting.
  theheart.org on Medscape, November 10, 2020
• Nov 6 2020 This Week in Cardiology   COVID, AF ablation, pediatric “do not dos” from AAP, heart failure performance measures, and a brief AHA preview are the topics discussed by John Mandrola, MD on this week’s podcast.
  theheart.org on Medscape, November 06, 2020
• Surgery Still Best Option in Obstructive HCM Promising results for a novel drug should not push surgical options aside for patients with obstructive hypertrophic cardiomyopathy, argue two surgeons.
  theheart.org on Medscape, October 15, 2020
• ESC 2020 Highlights: Treatment Strategies and the Virtual Experience   The first randomized trial on stopping ACE inhibitors and ARBs in patients with COVID-19, and a comparison of rhythm vs rate control in AF are among the strategies tested in trials presented at ESC 2020.
  theheart.org on Medscape, October 09, 2020
• HFpEF Management: 5 Things to Know Although proven medical therapies for HFpEF are few, a stepwise set of management practices can help optimize care for patients with this condition.
  American College of Cardiology & Medscape , October 07, 2020
• Smart Health Devices: Promises and Pitfalls What needs to be done before the data deluge hits the office.
  Medscape Medical News, September 30, 2020
• Sep 25 2020 This Week in Cardiology   COVID sport participation guidelines, beta-blockers after MI, and low-dose DOAC therapy in AF are the topics covered by John Mandrola, MD, in this week’s podcast.
  theheart.org on Medscape, September 25, 2020